CHS INC CHSCL
Nasdaq · XNAS · stock · Wholesale-Farm Product Raw Materials
Chart by TradingView
4/9
Piotroski F — financial health
3.02
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $35.5B | $597.9M | $1.1B | -$92.8M | $11.1B |
| 2024 | $39.3B | $1.1B | $1.8B | $464.1M | $10.8B |
| 2023 | $45.6B | $1.9B | $2.4B | $2.7B | $10.5B |
| 2022 | $47.8B | $1.7B | $2.1B | $1.6B | $9.5B |
| 2021 | $38.4B | $554.0M | $951.4M | $440.0M | $9.0B |
| 2020 | $28.4B | $422.4M | $981.8M | $668.9M | $8.8B |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.02 (safe)
- Working capital / assets 0.149
- Retained earnings / assets 0.16
- EBIT / assets 0.005
- Equity / liabilities 1.424
Source: SEC EDGAR filings · CIK 0000823277 · as of 2025-08-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.